Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.81)
# 3,148
Out of 4,884 analysts
787
Total ratings
30.43%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics | Assumes: Buy | $30 | $15.01 | +99.87% | 1 | Jul 1, 2025 | |
| PDSB PDS Biotechnology | Reiterates: Buy | $13 | $1.33 | +877.44% | 32 | Jul 1, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Buy | $42 | $13.03 | +222.33% | 1 | Jun 30, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $28.19 | +261.83% | 33 | Jun 25, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $14 | $2.40 | +483.33% | 2 | Jun 25, 2025 | |
| KRYS Krystal Biotech | Reiterates: Buy | $240 | $143.08 | +67.74% | 31 | Jun 24, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $77 | $10.25 | +651.22% | 23 | Jun 24, 2025 | |
| CDTX Cidara Therapeutics | Maintains: Buy | $41 → $53 | $48.78 | +8.65% | 2 | Jun 24, 2025 | |
| LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $4 | $0.90 | +343.95% | 22 | Jun 24, 2025 | |
| ATNM Actinium Pharmaceuticals | Reiterates: Buy | $4 | $1.44 | +177.78% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.01 | +791.09% | 12 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.34 | +1,076.47% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.17 | +1,267.52% | 29 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $2.18 | +175.23% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.49 | +479.06% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $22.00 | +127.27% | 35 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $5.81 | +175.39% | 20 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.44 | +594.44% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $5.31 | +559.13% | 9 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.50 | - | 4 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $26.96 | +285.76% | 24 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.17 | +314.75% | 15 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.81 | +839.23% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $12.98 | +146.53% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $15 | $0.44 | +3,309.09% | 15 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.61 | +893.79% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $5.61 | +4,356.33% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $1.75 | +1,042.86% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.96 | +833.71% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.66 | +984.34% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $15 | $7.54 | +98.94% | 9 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.86 | +582.59% | 26 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.75 → $4.5 | $1.43 | +215.79% | 22 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.61 | +717.13% | 16 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $2.78 | +763.31% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $34.66 | +246.22% | 48 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $7.13 | +124.40% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.70 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $3.90 | +694.87% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.65 | +1,743.32% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.83 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $10.58 | +249.72% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.93 | +469.95% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $18.93 | +201.11% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $7.13 | +194.53% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.74 | +1,049.43% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.12 | +1,079.25% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.62 | +472.52% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.88 | +1,282.98% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.80 | +557.89% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.19 | +8,303.36% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.23 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.74 | +1,739.08% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.33 | +1,187.55% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.20 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $36.72 | -10.13% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $4.80 | +1,525.00% | 1 | Mar 24, 2017 |
Travere Therapeutics
Jul 1, 2025
Assumes: Buy
Price Target: $30
Current: $15.01
Upside: +99.87%
PDS Biotechnology
Jul 1, 2025
Reiterates: Buy
Price Target: $13
Current: $1.33
Upside: +877.44%
Edgewise Therapeutics
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $13.03
Upside: +222.33%
Viking Therapeutics
Jun 25, 2025
Reiterates: Buy
Price Target: $102
Current: $28.19
Upside: +261.83%
Phio Pharmaceuticals
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.40
Upside: +483.33%
Krystal Biotech
Jun 24, 2025
Reiterates: Buy
Price Target: $240
Current: $143.08
Upside: +67.74%
Capricor Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $77
Current: $10.25
Upside: +651.22%
Cidara Therapeutics
Jun 24, 2025
Maintains: Buy
Price Target: $41 → $53
Current: $48.78
Upside: +8.65%
Lexicon Pharmaceuticals
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $0.90
Upside: +343.95%
Actinium Pharmaceuticals
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.44
Upside: +177.78%
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $1.01
Upside: +791.09%
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.34
Upside: +1,076.47%
Jun 17, 2025
Reiterates: Buy
Price Target: $16
Current: $1.17
Upside: +1,267.52%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $2.18
Upside: +175.23%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $4.49
Upside: +479.06%
Jun 16, 2025
Reiterates: Buy
Price Target: $50
Current: $22.00
Upside: +127.27%
Jun 13, 2025
Reiterates: Buy
Price Target: $16
Current: $5.81
Upside: +175.39%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $1.44
Upside: +594.44%
Jun 4, 2025
Reiterates: Buy
Price Target: $35
Current: $5.31
Upside: +559.13%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $26.96
Upside: +285.76%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $2.17
Upside: +314.75%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.81
Upside: +839.23%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $12.98
Upside: +146.53%
May 16, 2025
Maintains: Buy
Price Target: $21 → $15
Current: $0.44
Upside: +3,309.09%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $1.61
Upside: +893.79%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $5.61
Upside: +4,356.33%
May 9, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $1.75
Upside: +1,042.86%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.96
Upside: +833.71%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.66
Upside: +984.34%
Apr 30, 2025
Reiterates: Buy
Price Target: $11 → $15
Current: $7.54
Upside: +98.94%
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $5.86
Upside: +582.59%
Apr 25, 2025
Maintains: Buy
Price Target: $5.75 → $4.5
Current: $1.43
Upside: +215.79%
Apr 25, 2025
Reiterates: Buy
Price Target: $5
Current: $0.61
Upside: +717.13%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $2.78
Upside: +763.31%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $34.66
Upside: +246.22%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $7.13
Upside: +124.40%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.70
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $3.90
Upside: +694.87%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.65
Upside: +1,743.32%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.83
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $10.58
Upside: +249.72%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.93
Upside: +469.95%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $18.93
Upside: +201.11%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $7.13
Upside: +194.53%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.74
Upside: +1,049.43%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.12
Upside: +1,079.25%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.62
Upside: +472.52%
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.88
Upside: +1,282.98%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.80
Upside: +557.89%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.19
Upside: +8,303.36%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.23
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.74
Upside: +1,739.08%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.33
Upside: +1,187.55%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.20
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $36.72
Upside: -10.13%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $4.80
Upside: +1,525.00%